Is the World Health Organization-recommended dose of pralidoxime effective in the treatment of organophosphorus poisoning? A randomized, double-blinded and placebo-controlled trial

Is the World Health Organization-recommended dose of pralidoxime effective in the treatment of organophosphorus poisoning? A randomized, double-blinded and placebo-controlled trial

Background: Organophosphorus poisoning (OPP) is a major global public health problem. Pralidoxime has been used in a complimentary role to atropine for the management of OPP. World Health Organization (WHO) recommends use of pralidoxime but studies regarding its role have been inconclusive, ranging...

Full description

Bibliographic Details
Main Authors: Sumaya Syed, Showkat Ahmad Gurcoo, Ayaz Khalid Farooqui, Waqarul Nisa, Khalid Sofi, Tariq M Wani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Saudi Journal of Anaesthesia
Subjects:
Acetyl-cholinesterase
atropine
organophosphorous poisoning
pralidoxime
pseudo-cholinesterase
ventilation
Online Access:http://www.saudija.org/article.asp?issn=1658-354X;year=2015;volume=9;issue=1;spage=49;epage=54;aulast=Syed

Internet

http://www.saudija.org/article.asp?issn=1658-354X;year=2015;volume=9;issue=1;spage=49;epage=54;aulast=Syed

Similar Items